The Securities and Exchange Commission (SEC) opened an extension office here Thursday, the 14th nationwide, to strengthen its ...
Johnson & Johnson today announced the nipocalimab Biologics License Application (BLA) received Priority Review designation from the U.S Food and Drug Administration (FDA) for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback